
|Articles|March 20, 2008
CVS to pay almost $37 million to settle switching of ranitidine
CVS reaches $36.7 million settlement agreement on retail dispensing practices for ranitidine.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Navigating Compounding Peptides and GLP-1s Through Regulations
2
The 2026 GLP-1 Compounding Crackdown: A Pharmacist’s Guide
3
Understanding the Restructure of US Pharmacy Benefits Amid Reform, Regulatory Action
4
Pharmacist Involvement Speeds Prior Authorization for GLP-1s
5


























